The Union Ministry of Health and Family Welfare on 19 November 2026 proposed writing Good Storage and Distribution Practices (GSDP) for medicines into the Drugs Rules, 1945, so that the quality of a medicine is protected all the way from the factory or importer to the point where it is handed to a patient, according to a ministry release issued in New Delhi.

The draft has been published in the official gazette and is open for objections and suggestions from the public and stakeholders.

What would change for medicines you buy?

The aim is that a medicine reaching a patient is in the same condition it left the manufacturer, the ministry said. The framework is meant to keep products within their specified quality and environmental conditions during storage and transport, and to cut the risk of deterioration, contamination, mix-ups, falsification, diversion and unauthorised distribution.

The guidelines would cover every stage of distribution, including procurement, purchasing, storage, distribution, transportation, documentation and record-keeping, according to the release.

Who would it apply to?

The ministry said the rules would increase accountability among manufacturers, importers, wholesalers, distributors, stockists and other entities in the distribution chain. They would also give Central and State drug-control authorities a firmer legal basis for oversight, inspection and enforcement, and push for better documentation and traceability.

Where does this come from?

The proposal builds on GSDP guidance already developed by the Central Drugs Standard Control Organisation (CDSCO), India's national drug regulator. Turning that guidance into rules under the Drugs Rules, 1945 would make it part of the binding regulatory framework, the release indicates. The ministry described the move as a step towards strengthening India's pharmaceutical quality-management system beyond the manufacturing stage.

It is one of several draft changes to drug rules the ministry announced this week, including a separate licence for bulk drug wholesalers and central approval for antimicrobials.

How can the public respond?

Objections and suggestions can be sent to the Under Secretary (Drugs Regulation), Ministry of Health and Family Welfare, U-6, Work Hall, C Wing, First Floor, Kartavya Bhawan-1, New Delhi 110001, or by email to drugsdiv-mohfw[at]gov[dot]in. The draft notification is available on the e-Gazette website.

What is not yet clear

The release does not give the deadline for comments, the date from which the rules would apply, or the specific requirements, such as temperature limits or record formats, that businesses would have to meet. Those details are expected to be in the gazette notification, which could not be accessed for this report. The rules will take effect only after the ministry considers the comments and issues a final notification.

Photo source